Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Berberich

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Oncogene|August 20, 2008
Full-length hdmX transcripts decrease following genotoxic stressM Markey, S J Berberich
Molecular and Cellular Biology|January 11, 2000
MdmX protects p53 from Mdm2-mediated degradationM W Jackson, S J Berberich
Oncogene|June 15, 1995
PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive elementS J Berberich, E H Postel
Genes & Development|February 1, 1992
Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimersS J Berberich, M D Cole
Biochimica Et Biophysica Acta|May 9, 2001
p53 binds to cisplatin-damaged DNAC C Wetzel, S J Berberich
DNA and Cell Biology|September 24, 1999
Constitutive mdmx expression during cell growth, differentiation, and DNA damageM W Jackson, S J Berberich
Oncogene|December 5, 1996
Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiationL D Mayo, S J Berberich
Oncology Research|August 13, 1998
DNA binding activities of p53 protein following cisplatin damage of ovarian cellsC C Wetzel, S J Berberich
DNA and Cell Biology|July 11, 2001
Regulation of p63 function by Mdm2 and MdmXM Kadakia, C Slader, S J Berberich
Cancer Research|November 26, 1997
Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53L D Mayo, J J Turchi, S J Berberich
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Oncogene|August 20, 2008
Full-length hdmX transcripts decrease following genotoxic stressM Markey, S J Berberich
Molecular and Cellular Biology|January 11, 2000
MdmX protects p53 from Mdm2-mediated degradationM W Jackson, S J Berberich
Oncogene|June 15, 1995
PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive elementS J Berberich, E H Postel
Genes & Development|February 1, 1992
Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimersS J Berberich, M D Cole
Biochimica Et Biophysica Acta|May 9, 2001
p53 binds to cisplatin-damaged DNAC C Wetzel, S J Berberich
DNA and Cell Biology|September 24, 1999
Constitutive mdmx expression during cell growth, differentiation, and DNA damageM W Jackson, S J Berberich
Oncogene|December 5, 1996
Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiationL D Mayo, S J Berberich
Oncology Research|August 13, 1998
DNA binding activities of p53 protein following cisplatin damage of ovarian cellsC C Wetzel, S J Berberich
DNA and Cell Biology|July 11, 2001
Regulation of p63 function by Mdm2 and MdmXM Kadakia, C Slader, S J Berberich
Cancer Research|November 26, 1997
Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53L D Mayo, J J Turchi, S J Berberich
Pageof 2